Infliximab is administered by intravenous infusion. What is its dosing in this material?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Infliximab is administered by intravenous infusion. What is its dosing in this material?

Explanation:
Infliximab is given by intravenous infusion with weight-based dosing. In this material, the typical regimen is 5 mg per kilogram of body weight administered as an IV infusion at weeks 0, 2, and 6, then every 8 weeks thereafter. This contrasts with the other agents listed, which are given by subcutaneous injections on fixed schedules (for example, adalimumab and certolizumab are SC injections, and etanercept is usually SC weekly or biweekly).

Infliximab is given by intravenous infusion with weight-based dosing. In this material, the typical regimen is 5 mg per kilogram of body weight administered as an IV infusion at weeks 0, 2, and 6, then every 8 weeks thereafter. This contrasts with the other agents listed, which are given by subcutaneous injections on fixed schedules (for example, adalimumab and certolizumab are SC injections, and etanercept is usually SC weekly or biweekly).

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy